North Liberty-based Steel Therapeutics secures $2M in strategic investment
Summary
Steel Therapeutics closed a $2 million strategic investment round to fund development of its Fizurex wipe. The company will use the money to advance a pivotal toxicology study and prepare an IND submission. Steel Therapeutics is moving from early formulation and proof-of-concept work into preclinical development and regulatory engagement. Its first product targets anal fissures and aims to offer a more consistent alternative to compounded treatments. The company also plans first-in-human studies next year.
Funding
Amount
$2.0M
Total raised
Date
December 5, 2024
Announcement date
Investors
-
Lead investors
Company
https://www.steeltherapeutics.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected